Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma

Glioblastoma (GBM), the most common and malignant brain tumor, is classified according to its isocitrate dehydrogenase (IDH) mutation status in the 2016 World Health Organization (WHO) brain tumor classification scheme. The standard treatment for GBM is maximal resection, radiotherapy, and Temozolom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Molecules
Main Authors: Adilijiang, Alimu, Hirano, Masaki, Okuno, Yusuke, Aoki, Kosuke, Ohka, Fumiharu, Maeda, Sachi, Tanahashi, Kuniaki, Motomura, Kazuya, Shimizu, Hiroyuki, Yamaguchi, Junya, Wakabayashi, Toshihiko, Natsume, Atsushi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749405/
https://ncbi.nlm.nih.gov/pubmed/31443404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24173046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados